Research Focus

Surgery; Senior Office Coordinator, Hospital Operations

Recent additions – View all

1. eVOLVE-Meso: A global phase 3 study of first-line volrustomig plus chemotherapy in unresectable pleural mesothelioma

   Meeting Abstract

   Scherpereel, A.; Fennell, D. A.; Fujimoto, N.; Marmarelis, M. E.; Tsao, A.; Aerts, J.; Li, X.; Dalvi, T.; Jiang, H.; Krug, L.; more...
   Journal of Thoracic Oncology (2024)

   Fulltext@MSK | Save